PUBLICATIONS

"Redefining Health Care: Creating Value Based Competition on Results"  Harvard Business School Press.  Forthcoming 2006, co-authored with Michael E. Porter.

“Redefining Competition in Health Care,” June 2004. Harvard Business Review, pp 64-77. Co-authored with Michael E. Porter.

“Fixing Competition in U.S. Health Care” June 2004. HBR Research Report. Product number 7081. Co-authored with Michael E. Porter.

“Managing Ideas,” Autumn 2003, Batten Briefings. Co-authored with C. Thompson and K. Ramdas

The Portable MBA, Fourth Edition, John Wiley & Sons, Inc., New York, 2003. Co-authored with R.F. Bruner, M.R. Eaker, R.E. Freeman, R.E. Spekman and S. Venkataraman.

“Sustainable Business: Opportunity and Value Creation,” INTERFACES, 30, No. 3, May-June 2000, pp. 1-12. Co-authored with A. Larson and R. Johnson.

Special Issue of INTERFACES on Sustainable Business, May-June 2000, co-editor with A. Larson.

“Introduction: Strategy, Modeling and Analysis,” INTERFACES, November-December 1999, 29, No. 6, pp. 1-3. Co-authored with S. Bodily.

Special Issue of INTERFACES on Strategy, Analysis and Models, November-December 1999, 29, No. 6, co-editor with S. Bodily.

The Portable MBA, Third Edition, John Wiley & Sons, Inc., New York, 1998. Co-authored with R.F. Bruner, M.R. Eaker, R.E. Freeman, and R.E. Spekman.
-translated into Japanese (1998), Portuguese (1999), Chinese (1999) and Russian (2000)

A Script - Innovation Is the Key, EIU Healthcare International, 1st Quarter 1997, Economist Intelligence Unit Limited 1997, pp. 79-88. Co-authored with Gregory B. Brown.

"The Role of Biomedical Research in Health Care Reform." Science, October 7, 1994. Co-authored with Mark W. Kirschner and Elizabeth Marincola.

"The Debate on Health Care Reform Continues ..." Harvard Business Review, November-December 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

"Finding a Lasting Cure for U.S. Health Care." Perspectives column. Harvard Business Review, September-October 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

"Making Competition in Health Care Work." Harvard Business Review, July-August 1994, vol. 72, no. 4, pp. 131-141. Co-authored with Michael E. Porter and Gregory B. Brown.

"Methods for Evaluating Capital Investment Decisions Under Uncertainty." Real Options in Capital Investment: New Contributions, edited by Lenos Trigeorgis. Westport, CT: Praeger Publishing, 1995.

"An Option Valuation Analysis of Investment Choices by a Regulated Firm." Management Science, April 1994, vol. 40, no. 4, pp. 535-548.

"Innovation: Medicine's Best Cost-Cutter."  The New York Times, February 27, 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

"Capital Investment Strategies Under Uncertain Regulation" The RAND Journal of Economics, Winter 1993, vol. 24, no. 4, pp. 591-604.

"The Value of Commodity Purchase contracts with Limited Price Risk." The Energy Journal, 1991, vol. 12, no. 3, pp. 109-135. Co-authored with Thomas J. Teisberg.

"When Choosing R&D Projects, Go with Long Shots." Research-Technology Management, January-February 1991. Co-authored with A.L. Kolbe and P.A. Morris.

"Investment Cost Recovery and Incentives for Power Plant Construction." Public Utilities Fortnightly, March 3, 1988, vol. 121, no. 5, pp. 9-14.

"Evaluating the Effects of Time and Risk on Investment Choices: A Comparison of Finance and Decision Analysis." Electric Power Research Institute Project 2379-4, January 1987. Co-authored with A.L. Kolbe and P.A. Morris.

"Analyzing R&D and Policy Options for the Greenhouse Effect," in The Energy Industries in Transition: 1985-2000, Part I edited by J.P. Weyant and D.B. Sheffield, International Association of Energy Economists, 1984. Co-authored with B.R. Judd and L.J. Pollenz. Summary version published in proceedings of the 78th Annual Meeting of the Air Pollution Control Association. Detroit, MI. June 16, 1985.


Case/Course Development

Conceptual Notes

Option Valuation: Insights and Explanations Using a Binomial Approach
July 1999, UVA-OM-0900

“The Path to Sustainable Business: Environmental Frameworks, Practices and Related Tools”
1997, Rev. May, 1998, UVA-G-0534

"Why Do Good Managers Choose Poor Strategies?"
April 1991, Harvard Business School, #9-391-172

"Strategic Response to Uncertainty."
April 1993, Harvard Business School, #9-391-192

"Strategic Response to Uncertainty: Competition and Strategy Module Introduction for Instructors."
June 1993, Harvard Business School, #5-793-143


Cases and Teaching Notes
 

Sarcos Research Corp 2004, UVA-S-0119

Sarcos Research Corp (TN) 2004, UVA-S-0119TN

Barraquer Clinic 2004

Managing Health Benefits: The Dilemma of Joining the Leapfrog Group (A)

2004, UVA-S-0113

Managing Health Benefits: The Dilemma of Joining the Leapfrog Group (B)

2004, UVA-S-0114

Wal*Mart in the 21st Century a Global Perspective S-0100

NTT DoCoMo: The Pioneer of Mobile Internet
2002, UVA-OM-0974

NTT DoCoMo (B) 2002, UVA-OM-1057

NTT DoCoMo 2003, UVA- ENT 0048

Magnetic Surgery System (A)
December 1999, UVA-OM-0888

Magnetic Surgery System: B, C, D and E
December 1999, UVA-OM-0889, 0890, 0891 and 0892

Managing Innovation at GE Medical Systems (A)
December 1998, UVA-OM-0882

Managing Innovation at GE Medical Systems (B)
1999, UVA-OM-0883

Seaflower Associates, Inc.: Valuing Venture Capital with Real Options
January, 1999, UVA-OM-0884

Zoll Medical Corporation.
December 1994, Harvard Business School, #9-795-053

Zoll Medical Corporation: B and C
December 1994, Harvard Business School, #9-795-054 and #9-795-055

Digital Imaging in 1995: Opportunities in the Descent to the Desktop
April 1996, Harvard Business School, #9-796-060

Active Coatings, Inc. (A) - Challenges in Managing Product Development
February 1996, Harvard Business School, #9-796-061

Active Coatings, Inc. (B) - Challenges in Managing Product Development
February 1996, Harvard Business School, 9-796-062

Note on the FDA Approval Process for Medical Devices
November 1995, Harvard Business School, #9-796-063

Alpha-Beta Technology, Inc., Pioneering Carbohydrate Technology
February, 1994, Harvard Business School, #9-794-093

Alpha-Beta Technology, Inc. (B): Trials with Betafectin
December, 1994, Harvard Business School, #9-795-045

Diagnosis for the Future: The Genetic Testing Industry in 1993
February 1994, Harvard Business School, Case #9-794-053

IG Laboratories Inc. (A): Pursuing the Future of Genetic Testing
October 1994, Harvard Business School, #9-794-054

IG Laboratories, Inc. (B): The Paradox of Growth – 1993-94
February 1996, Harvard Business School, #9-796-114

Genzyme Corporation
April 1993, Rev. May 1994, Harvard Business School, Case #9-793-120 and Teaching Note #5-793-122

Biotechnology Strategies in 1992
April 1992, Rev. June 1993, Harvard Business School, Case #9-792-082 and Teaching Note #5-793-036

McCaw Cellular Communications, Inc. in 1990
April 1991, Rev. June, 1993, Harvard Business School, Case #9-391-171 and Teaching Note #5-792-016

McCaw Cellular Communications, Inc. (B-E)
March 1993, Rev. June 1993, April 1993, May 1993, March 1993, Harvard Business School, Cases #9-793-050-053 and Teaching Note #5-793-061

The Brigham and Women's Hospital in 1992
April 1992, Rev. March 1993, Harvard Business School, Case #9-792-095 and Teaching Note #5-792-010

The Hospital Sector in 1992
April 1991, Rev. April 1992, Harvard Business School, Case #9-391-167 and Teaching Note #5-792-011

The Desktop Printer Industry in 1990
June 1990, Rev. January 1994, Harvard Business School, Case #9-390-173 and Teaching Note #5-391-075

Pennzoil Company
March 1990, Rev. May 1993, Harvard Business School, Case #9-390-131 and Teaching Note #5-391-074